Abstract
The aim of this study was to compare the socioeconomic consequences of early and late rheumatoid arthritis in Belgium and to assess the patient out-of-pocket contributions. This multicentre longitudinal study in Belgium evaluated patients with rheumatoid arthritis. Early disease was defined as diagnosis since less than 1 year. At baseline sociodemographic and disease characteristics were assessed and during the following year patients recorded all healthcare- and non-healthcare-related direct costs and out-of-pocket contributions. The study included 48 patients with early and 85 patients with late rheumatoid arthritis. Mean disease duration was 0.5 vs 12.5 years in patients with early and late rheumatoid arthritis, respectively. The disease activity score (DAS28) was comparable between both groups (4.1 vs 4.5, p=0.14), but physical function (Health Assessment Questionnaire, HAQ) was more impaired in patients with long-standing disease (1.0 vs 1.7, p<0.001). Work disability had increased from 2% in patients with early to 18% in patients with late disease. The annual societal direct costs per patient were € 3055 (median: € 1518) opposed to € 9946 (median: € 4017) for early and late rheumatoid arthritis, respectively. The higher direct cost for patients with long-standing disease was seen for all categories, but especially for physiotherapy and need for devices and adaptations. Patients with early as well as late disease contribute out of pocket about one-third to the direct healthcare costs. Within each group, HAQ was a strong determinant of costs. In Belgium, patients with long-standing rheumatoid arthritis are nine times more likely to be work disabled than patients with less than 1 year disease duration and have a threefold increase in costs. Differences in healthcare consumption between patients could be mainly explained by differences in physical function (HAQ).
Similar content being viewed by others
References
Cooper NJ (2000) Economic burden of rheumatoid arthritis: a systematic review. Rheumatology 39:28–33
Yelin E, Wanke LA (1999) An assessment of the annual and long term direct costs of rheumatoid arthritis: the impact of poor functioning and functional decline. Arthritis Rheum 42:1209–1218
Van Jaarsveld CH, Jacobs JW, Schrijvers AJ et al (1998) Direct cost of rheumatoid arthritis during the first six years: a cost of illness study. Br J Rheumatol 37:837–847
Arnett FC, Edworthy SM, Bloch DA, Mc Shane DJ, Fries JF, Cooper NS et al (1988)The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Lajas C, Abasolo L, Bellajdel B et al (2003) Costs and predictors of costs in rheumatoid arthritis: a prevalence based study. Arthritis Rheum 49:64–70
Pugner KM, Scott DI, Holmes JW, Hieke K (2000) The costs of rheumatoid arthritis: an international long-term view. Semin Arthritis Rheum 29:305–320
Verstappen SMM, Verkleij H, Bijlsma JWJ et al (2004) Determinants of direct costs in Dutch rheumatoid arthritis patients. Ann Rheum Dis 63:817–824
Kaipiainen-Sepanen O, Aho K, Isomaki H, Laakso M (1996) Incidence of rheumatoid arthritis in Finland during 1980–1990. Ann Rheum Dis 55:608–611
Imanaka T, Shichikawa K, Inoue K, Shimaoka Y, Takenada Y, Wakitani S (1997)Increase in age at onset of rheumatoid arthritis in Japan over a 30 year period. Ann Rheum Dis 56:313–316
Acknowledgements
The authors wish to thank Dr. Veerle Taelman, Dr. Kristien Maenaut, Dr. Kathleen Declerck, Dr. Ellie Kruithof and all the participating patients for their tremendous effort to collect all the data. This study was financially supported by an Educational Grant from Aventis Belgium.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Westhovens, R., Boonen, A., Verbruggen, L. et al. Healthcare consumption and direct costs of rheumatoid arthritis in Belgium. Clin Rheumatol 24, 615–619 (2005). https://doi.org/10.1007/s10067-005-1119-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-1119-4